Company Filing History:
Years Active: 2001-2004
Title: Basel H. Taha: Innovator in Cardiac Analysis Technology
Introduction
Basel H. Taha, a distinguished inventor based in Menomonee Falls, WI, has made significant contributions to the field of cardiac analysis technology. With a total of five patents to his name, Taha's innovative work focuses on improving the methods used to analyze and manipulate physiological data from electrocardiograms (ECGs).
Latest Patents
Among his latest patents, Taha introduced a groundbreaking method and apparatus for dynamically selecting an electrocardiogram compression process based on computerized analysis of cardiac rhythm and contour. This method allows for the automatic selection of a physiological data manipulation process that separates asynchronous components with diagnostic information from synchronous components during data analysis. Another significant patent involves using spectral measures to distinguish among atrial fibrillation, atrial flutter, and other cardiac rhythms. This invention estimates spectral entropy from a patient's ECG to identify atrial fibrillation when the spectral entropy exceeds a predetermined threshold.
Career Highlights
Taha has worked with several prominent companies, including GE Medical Systems Information Technologies and GE Marquette Medical Systems, where he contributed to cutting-edge advancements in medical technology. His work has potentially revolutionized the way cardiac conditions are diagnosed and analyzed.
Collaborations
Throughout his career, Taha has collaborated with notable professionals, including Shankara Bonthu Reddy and Joel Qiuzhen Xue. These collaborations have played a pivotal role in enhancing the research and development of innovative cardiac analysis solutions.
Conclusion
Basel H. Taha exemplifies the spirit of innovation in the medical field, particularly in the realm of cardiac rhythm analysis. His patents reflect a profound understanding of both technology and cardiology, paving the way for advancements that may improve patient outcomes and diagnostic accuracy in the future.